ENDPOINTS

How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruition

About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting the leadership of Tanabe Pharma and its parent Mitsubishi Chemical ...

Feb 14, 2025 - 16:29
 0
How Bain’s $3.3B deal for a centuries-old Japanese pharma came to fruition
About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting the leadership of Tanabe Pharma and its parent Mitsubishi Chemical ...
Read More

Tags:

Previous Article

Mil-Sim Shooter ‘Onward’ Announces First Major Update After a Year-long Wait

Next Article

Farmers used trash to grow crops in barren sand 1000 years ago

Related Posts

BioNTech vets raise about $90M in Series A for bispecific immunology research

BioNTech vets raise about $90M in Series A for bispecif...

Feb 14, 2025  0

AbbVie pens another T cell engager deal, this time with Xilio

AbbVie pens another T cell engager deal, this time with...

Feb 12, 2025  0

Why UnitedHealth Group is offering 30,000 voluntary buyouts to its employees

Why UnitedHealth Group is offering 30,000 voluntary buy...

Feb 20, 2025  0